ACTIVATION AND INACTIVATION OF A VARIETY OF MUTAGENIC COMPOUNDS BY THE RECONSTITUTED SYSTEM CONTAINING HIGHLY PURIFIED PREPARATIONS OF CYTOCHROME-P-450 FROM RAT-LIVER

被引:22
作者
KAWANO, S
KAMATAKI, T
MAEDA, K
KATO, R
NAKAO, T
MIZOGUCHI, I
机构
[1] TOKYO METROPOLITAN RES LAB PUBL HLTH,SHINJUKU KU,TOKYO 160,JAPAN
[2] HOSHI UNIV,DEPT PHARMACOL,SHINAGAWA KU,TOKYO 142,JAPAN
来源
FUNDAMENTAL AND APPLIED TOXICOLOGY | 1985年 / 5卷 / 03期
关键词
D O I
10.1016/0272-0590(85)90096-X
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
引用
收藏
页码:487 / 498
页数:12
相关论文
共 41 条
[1]   METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST [J].
AMES, BN ;
MCCANN, J ;
YAMASAKI, E .
MUTATION RESEARCH, 1975, 31 (06) :347-363
[2]   INVIVO AND INVITRO EFFECTS OF 3-METHYLCHOLANTHRENE ON THE MICROSOME-MEDIATED INVITRO MUTAGENICITY OF 2-ACETYLAMINOFLUORENE [J].
BATARDYGREGOIRE, M ;
RAZZOUK, C ;
AGAZZILEONARD, E ;
MERCIER, M ;
PONCELET, F ;
ROBERFROID, M .
TOXICOLOGY LETTERS, 1981, 7 (06) :385-392
[3]  
CONNEY AH, 1982, CANCER RES, V42, P4875
[4]  
CUATRECASAS P, 1970, J BIOL CHEM, V245, P3059
[5]   METABOLISM OF THE MUTAGENIC ENVIRONMENTAL-POLLUTANT, 6-NITROBENZO[A]PYRENE - METABOLIC-ACTIVATION VIA RING OXIDATION [J].
FU, PP ;
CHOU, MW ;
YANG, SK ;
BELAND, FA ;
KADLUBAR, FF ;
CASCIANO, DA ;
HEFLICH, RH ;
EVANS, FE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 105 (03) :1037-1043
[6]   PURIFICATION AND CHARACTERIZATION OF LIVER MICROSOMAL CYTOCHROMES-P-450 - ELECTROPHORETIC, SPECTRAL, CATALYTIC, AND IMMUNOCHEMICAL PROPERTIES AND INDUCIBILITY OF 8 ISOZYMES ISOLATED FROM RATS TREATED WITH PHENOBARBITAL OR BETA-NAPHTHOFLAVONE [J].
GUENGERICH, FP ;
DANNAN, GA ;
WRIGHT, ST ;
MARTIN, MV ;
KAMINSKY, LS .
BIOCHEMISTRY, 1982, 21 (23) :6019-6030
[7]   METABOLIC ACTIVATION OF AFLATOXINS RELATED TO THEIR MUTAGENICITY [J].
GURTOO, HL ;
DAHMS, RP ;
PAIGEN, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 81 (03) :965-972
[8]   METABOLIC-ACTIVATION OF MUTAGENIC TRYPTOPHAN PYROLYSIS PRODUCTS (TRP-P-1 AND TRP-P-2) BY A PURIFIED CYTOCHROME P-450-DEPENDENT MONO-OXYGENASE SYSTEM [J].
ISHII, K ;
ANDO, M ;
KAMATAKI, T ;
KATO, R ;
NAGAO, M .
CANCER LETTERS, 1980, 9 (04) :271-276
[9]  
KAMATAKI T, 1976, MOL PHARMACOL, V12, P921
[10]   PARTIAL-PURIFICATION AND CHARACTERIZATION OF CYTOCHROME-P-450 RESPONSIBLE FOR THE OCCURRENCE OF SEX DIFFERENCE IN DRUG-METABOLISM IN THE RAT [J].
KAMATAKI, T ;
MAEDA, K ;
YAMAZOE, Y ;
NAGAI, T ;
KATO, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 103 (01) :1-7